Maegan Deegan

VP, Clinical Operations

Maegan is a seasoned clinical operations professional with nearly 20 years of clinical research experience.  Most recently, she served as Vice President of Clinical Operations at Elevation Oncology, a small precision oncology company.  She has extensive experience driving high performing global clinical programs across all stages of development. 

Maegan started her career as a Research Associate at Yale Medical School.  In her first industry role, Maegan contributed to Bristol Myers Squibb’s first approval for Nivolumab in patients with metastatic melanoma.  Since then, Maegan has worked on a number of programs that resulted in approvals at small biotechnology companies including Loxo Oncology and Biohaven Pharmaceuticals.